Literature DB >> 10217055

Biological determinants of cancer progression in men with prostate cancer.

T A Stamey1, J E McNeal, C M Yemoto, B M Sigal, I M Johnstone.   

Abstract

CONTEXT: The recent increase in ability to diagnose prostatic adenocarcinoma has created a dilemma for treatment decisions.
OBJECTIVE: To determine whether prostate cancer progression is associated with a modified version of the Gleason grading system together with selected morphologic and clinical variables.
DESIGN: Retrospective analysis of a cohort of patients with peripheral zone prostate cancers who underwent surgery between August 1983 and July 1992.
SETTING: University hospital. PATIENTS: Radical prostatectomy specimens from 379 men treated only by surgical excision were prospectively studied for 8 morphologic variables using previously standardized techniques. Variables were percentage of each cancer occupied by Gleason grade 4/5 (% Gleason grade 4/5, the Stanford modified Gleason scale), cancer volume, vascular invasion, lymph node involvement, seminal vesicle invasion, capsular penetration, positive surgical margin, prostate weight, and preoperative prostate-specific antigen (PSA) level. MAIN OUTCOME MEASURE: Biochemical progression of prostate cancer as indicated by serum PSA level of 0.07 ng/mL and increasing.
RESULTS: Cancer grade expressed as % Gleason grade 4/5 and cancer volume were highly predictive of disease progression. In a Cox proportional hazards model that included % Gleason grade 4/5, the traditional Gleason score was not an independent predictor of treatment failure. Positive lymph node findings and intraprostatic vascular invasion were the only other variables that remained significant at the .01 level.
CONCLUSION: The % Gleason grade 4/5, cancer volume, positive lymph node findings, and intraprostatic vascular invasion were independently associated with prostate cancer progression, defined by an increasing PSA level. Techniques to accurately measure cancer volume and % Gleason grade 4/5 are needed to better predict which patient will experience cancer progression. The commonly accepted predictors of progression-capsular penetration and positive surgical margins-were not independently predictive of failure after radical prostatectomy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217055     DOI: 10.1001/jama.281.15.1395

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  116 in total

Review 1.  Methods for volume assessment of prostate cancer.

Authors:  Heinz-Peter Schlemmer; Stefan Corvin
Journal:  Eur Radiol       Date:  2004-02-06       Impact factor: 5.315

Review 2.  [Indications for and results of radical prostatectomy].

Authors:  M Graefen; P G Hammerer; A Haese; H Huland
Journal:  Urologe A       Date:  2003-09       Impact factor: 0.639

3.  Prognostic factors identifying biochemical recurrence in patients with positive margins after radical prostatectomy.

Authors:  Ioannis Anastasiou; Stavros I Tyritzis; Ioannis Adamakis; Dionysios Mitropoulos; Konstantinos G Stravodimos; Ioannis Katafigiotis; Antonios Balangas; Anastasios Kollias; Kitty Pavlakis; Constantinos A Constantinides
Journal:  Int Urol Nephrol       Date:  2010-10-30       Impact factor: 2.370

4.  Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods.

Authors:  Ian M Thompson; Shady Salem; Sam S Chang; Peter E Clark; Rodney Davis; S Duke Herrell; Yakup Kordan; Roxelyn Baumgartner; Sharon Phillips; Joseph A Smith; Michael S Cookson; Daniel A Barocas
Journal:  World J Urol       Date:  2010-11-16       Impact factor: 4.226

5.  Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer.

Authors:  Denong Wang; Laila Dafik; Rosalie Nolley; Wei Huang; Russell D Wolfinger; Lai-Xi Wang; Donna M Peehl
Journal:  Drug Dev Res       Date:  2013-03       Impact factor: 4.360

6.  Semi-automatic deformable registration of prostate MR images to pathological slices.

Authors:  Yousef Mazaheri; Louisa Bokacheva; Dirk-Jan Kroon; Oguz Akin; Hedvig Hricak; Daniel Chamudot; Samson Fine; Jason A Koutcher
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

7.  Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems.

Authors:  Sonia Gaur; Stephanie Harmon; Lauren Rosenblum; Matthew D Greer; Sherif Mehralivand; Mehmet Coskun; Maria J Merino; Bradford J Wood; Joanna H Shih; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  AJR Am J Roentgenol       Date:  2018-05-07       Impact factor: 3.959

8.  Role of endorectal coil magnetic resonance imaging in treatment of patients with prostate cancer and in determining radical prostatectomy surgical margin status: report of a single surgeon's practice.

Authors:  Jian Qing Zhang; Kevin R Loughlin; Kelly H Zou; Steven Haker; Clare M C Tempany
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

9.  Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

Authors:  Julie Y An; Stephanie A Harmon; Sherif Mehralivand; Marcin Czarniecki; Clayton P Smith; Julie A Peretti; Bradford J Wood; Peter A Pinto; Peter L Choyke; Joanna H Shih; Baris Turkbey
Journal:  Abdom Radiol (NY)       Date:  2018-12

10.  Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrence.

Authors:  Jason P Izard; Lawrence D True; Philip May; William J Ellis; Paul H Lange; Bruce Dalkin; Daniel W Lin; Rodney A Schmidt; Jonathan L Wright
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.